查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1400594

辅酶 Q10 市场规模 -按应用（药品、膳食补充剂、化妆品）、研究报告、国家展望、价格趋势、成长前景、竞争产业份额和全球预测，2023-2032 年

Coenzyme Q10 Market Size - By Application (Pharmaceuticals, Dietary Supplements, Cosmetics), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Global Forecast, 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

由于该领域的蓬勃发展，全球辅酶 Q10 市场在 2023 年至 2032 年间的CAGR将超过 10.5%。随着人们对健康和保健的日益关注，研究揭示了辅酶 Q10 对心臟健康、能量产生和抗氧化特性的潜在益处，引起了人们的极大兴趣。

例如，2023 年11 月，伊朗研究人员团队撰写并发表在《国际生物化学研究》杂誌上的一篇题为“辅酶Q10 在各种神经退化性和精神疾病中的参与”的评论文章指出，辅酶Q10 (CoQ10)（一种内在抗氧化剂）存在于体内和某些食物中，可能有助于治疗弗里德赖希共济失调和其他神经系统疾病等疾病。研究人员提出，CoQ10 的抗氧化和能量调节特性可能会保护神经系统免于退化和衰退。

勘探的激增刺激了需求，迫使各行业创新和增强 CoQ10 配方以实现更广泛的应用。随着科学努力揭示其多方面的优势，市场成长轨迹与现代对改善健康解决方案的追求相一致。

辅酶 Q10 的整体市场份额根据应用和地区进行分类。

2023年至2032年，製药领域的辅酶Q10市场规模将出现显着的CAGR。製药业看重辅酶Q10在治疗心血管问题、神经系统疾病以及在癌症治疗中的潜在应用的作用。凭藉其抗氧化特性并参与细胞能量产生，辅酶 Q10 有望增强药物配方和补充各种疗法。药品需求的不断增长反映了人们对 CoQ10 的不断探索和利用，将其作为推进医疗干预措施以改善健康结果的重要组成部分。

亚太地区辅酶Q10产业将在2023年至2032年呈现出值得称讚的CAGR。随着预防保健意识的不断提高，膳食补充剂和化妆品中辅酶Q10的消费量将激增。这一趋势是由其抗氧化特性和据称对心臟健康的益处所推动的。此外，亚太地区的老年人口正在寻求 CoQ10，因为它具有解决与年龄相关的健康问题的潜力。

这种不断增长的需求反映了该地区对整体健康实践的倾向，推动了各行业 CoQ10 市场的成长。例如，2021 年 8 月，由总裁田中稔领导、总部位于东京港区的钟化株式会社宣布，辅酶 Q10 的活性变体可有效缓解短暂疲劳。最近的功能声明证实了它能够在暂时压力下提高睡眠品质、减轻这种压力并有助于维持口腔湿润。因此，由总裁 Shoji Nagae 领导、总部位于东京港区的 Kaneka Your Health Care Co., Ltd. 推出了名为“Watashi no ChikaraTM”的新颖产品系列，具有这些功能优势。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：全球辅酶 Q10 产业洞察

  • 行业细分
  • COVID-19 对世界经济的影响
  • 产业生态系统分析
    • 供应商矩阵
    • 配销通路分析
      • 经销商
      • 供应商
      • 合约起草（名词
      • 技术提供者
  • 原料分析：Covid-19 对供给的影响
    • Covid-19 对供应的影响
  • 产业格局，2018 - 2032
  • 技术景观
  • 监管环境
    • 欧洲
  • 定价分析
      • 区域定价：COVID-19 的影响
      • 成本结构分析
  • 产业影响力
    • 成长动力
      • 北美：化妆品需求不断成长
      • 欧洲：糖尿病和心血管疾病的盛行率不断上升
      • 亚太地区：医药市场扩张导致需求上升
    • 产业陷阱与挑战
      • 最低剂量要求
  • 创新与永续发展
  • 2022 年成长潜力分析
    • 新兴商业模式
      • 新产品发布
      • 合作
  • 波特的分析
  • 2022 年竞争格局
    • 2022 年公司市占率分析
    • 顶级球员概览
    • 战略仪表板
  • PESTEL分析
  • COVID-19 对辅酶 Q10 需求的影响（按应用划分）
    • 膳食补充剂
    • 药品
    • 化妆品
    • 其他的

第 4 章：全球辅酶 Q 10 市场：按应用

  • 主要应用趋势
  • 药品
  • 膳食补充剂
  • 化妆品
  • 其他的

第 5 章：全球辅酶 Q 10 市场：按地区

  • 主要区域趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 波兰
  • 亚太地区
    • 中国
    • 印度
    • 日本
  • 拉丁美洲 (LATAM)
    • 巴西
    • 墨西哥
  • 中东和非洲 (MEA)

第 6 章：公司简介

  • Kaneka Corporation
  • DSM
  • SourceOne Global Partners, LLC
  • Healthy Origins
  • Vitamin Shoppe, Inc.
  • NBTY, Inc.
  • Pharmavite LLC
  • QUTEN Research Institute LLC
  • Tishcon Corp.
  • Country Life, LLC
  • Natural Organics
  • Jarrow Formulas
  • NOW Foods
  • Pharma Nord, Inc.
  • Doctor's Best
  • Xiamen Kingdomway Group
  • GNC Holdings, Inc.
  • Nordic Naturals, Inc.

第 7 章：潜在客户

  • 默克公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 雅培实验室
    • 商业概览
    • 财务数据
    • 产品格局
  • 太阳药业有限公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 辉瑞公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 赛诺菲
    • 商业概览
    • 财务数据
    • 产品格局
  • 百时美施贵宝
    • 商业概览
    • 财务数据
    • 产品格局
  • 诺华公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 强生公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 葛兰素史克
    • 商业概览
    • 财务数据
    • 产品格局
  • 联合利华
    • 商业概览
    • 财务数据
    • 产品格局
  • 雅芳产品公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 拜尔斯多夫
    • 商业概览
    • 财务数据
    • 产品格局
  • 汉高股份公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 欧瑞莲控股公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 雅诗兰黛公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 伊夫·罗彻
    • 商业概览
    • 财务数据
    • 产品格局
  • 资生堂有限公司
    • 商业概览
    • 财务数据
    • 产品格局
  • 矢车菊营养
    • 商业概览
    • 财务数据
    • 产品格局
  • 巴林的
    • 商业概览
    • 财务数据
    • 产品格局
  • 自然因素
    • 商业概览
    • 财务数据
    • 产品格局
  • 延长寿命
    • 商业概览
    • 财务数据
    • 产品格局
Product Code: 741

Global Coenzyme Q10 Market will witness over 10.5% CAGR between 2023 and 2032 due to burgeoning research and development in the field. With increased focus on health and wellness, studies revealing CoQ10's potential benefits in heart health, energy production, and antioxidant properties have sparked immense interest.

For instance, in November 2023, A recent review article titled "Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases," penned by a team of Iranian researchers and published in Biochemistry Research International, suggested that Coenzyme Q10 (CoQ10), an intrinsic antioxidant present in the body and certain foods, could potentially aid in treating conditions like Friedreich's ataxia and other neurological ailments. The researchers propose that CoQ10's antioxidative and energy-regulating properties might safeguard the neurological system from degeneration and decline.

This surge in exploration fuels demand, compelling industries to innovate and enhance CoQ10 formulations for wider applications. As scientific endeavors unravel its multifaceted advantages, the market growth trajectory aligns with the quest for improved health solutions in modern times.

The overall Coenzyme Q10 Market share is classified based on application and region.

Coenzyme Q10 market size from the pharmaceuticals segment will register a noteworthy CAGR from 2023 to 2032. Pharmaceutical industries value CoQ10 for its role in treating cardiovascular issues, neurological disorders, and potential applications in cancer treatment. With its antioxidant properties and involvement in cellular energy production, CoQ10 holds promise in enhancing drug formulations and supplementing various therapies. This escalating demand within pharmaceuticals reflects the continuous exploration and utilization of CoQ10 as a vital component in advancing medical interventions for improved health outcomes.

Asia Pacific coenzyme Q10 industry will showcase a commendable CAGR from 2023 to 2032. With rising awareness of preventive healthcare, there is a surge in CoQ10 consumption in dietary supplements and cosmetics. This trend is propelled by its antioxidant properties and purported benefits in heart health. Moreover, Asia Pacific's aging population seeks CoQ10 for its potential in addressing age-related health concerns.

This increasing demand reflects the region's inclination toward holistic health practices, driving the CoQ10 market growth across diverse industries. For instance, in August 2021, Kaneka Corporation, led by President Minoru Tanaka and headquartered in Minato-ku, Tokyo, declared that the active variant of Coenzyme Q10 demonstrates efficacy in alleviating transient fatigue. Recent functional claims endorse its ability to enhance sleep quality amidst temporary stress, reduce such stress, and aid in sustaining oral moisture. Consequently, Kaneka Your Health Care Co., Ltd., helmed by President Shoji Nagae and also based in Minato-ku, Tokyo, introduced a novel product line named "Watashi no ChikaraTM," featuring these functional benefits.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Global coenzyme Q10 industry 360 degree synopsis, 2023 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Application trend

Chapter 3 Global coenzyme Q10 Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Impact of COVID-19 on world economy
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Vendor matrix
    • 3.3.2 Distribution channel analysis
      • 3.3.2.1 Distributor
      • 3.3.2.2 Suppliers
      • 3.3.2.3 Contract Manufacturing
      • 3.3.2.4 Technology providers
  • 3.4 Raw material analysis: Covid-19 impact on supply
    • 3.4.1 Covid-19 impact on supply
  • 3.5 Industry landscape, 2018 - 2032
  • 3.6 Technology landscape
  • 3.7 Regulatory landscape
    • 3.7.1 Europe
  • 3.8 Pricing analysis
      • 3.8.1.1 Regional pricing: COVID-19 impact
      • 3.8.1.2 Cost structure analysis
  • 3.9 Industry impact forces
    • 3.9.1 Growth drivers
      • 3.9.1.1 North America: Growing demand for cosmetics product
      • 3.9.1.2 Europe: Increasing prevalence of diabetes and cardiovascular diseases
      • 3.9.1.3 Asia Pacific: Pharmaceutical market expansion leading to rising demand
    • 3.9.2 Industry pitfalls & challenges
      • 3.9.2.1 Minimum dosage requirement
  • 3.10 Innovation & sustainability
  • 3.11 Growth potential analysis, 2022
    • 3.11.1 Emerging business model
      • 3.11.1.1 New Product Launch
      • 3.11.1.2 Collaboration
  • 3.12 Porter's analysis
    • 3.12.1 Bargaining power of suppliers
    • 3.12.2 Bargaining power of buyers
    • 3.12.3 Threat of new entrants
    • 3.12.4 Threat of substitutes
  • 3.13 Competitive landscape, 2022
    • 3.13.1 Company market share analysis, 2022
    • 3.13.2 Top players overview
    • 3.13.3 Strategy dashboard
  • 3.14 PESTEL analysis
  • 3.15 COVID-19 impact on Coenzyme Q10 demand, by application
    • 3.15.1 Dietary Supplements
    • 3.15.2 Pharmaceuticals
    • 3.15.3 Cosmetics
    • 3.15.4 Others

Chapter 4 Global Coenzyme Q 10 Market, By Application

  • 4.1 Key application trends
  • 4.2 Pharmaceuticals
    • 4.2.1 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
    • 4.2.2 Global coenzyme Q10 market from pharmaceutical application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.3 Dietary Supplements
    • 4.3.1 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
    • 4.3.2 Global coenzyme Q10 market from dietary supplements application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.4 Cosmetics
    • 4.4.1 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
    • 4.4.2 Global coenzyme Q10 market from cosmetics application, by region, 2018 - 2032, (Tons) (USD Million)
  • 4.5 Others
    • 4.5.1 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
    • 4.5.2 Global coenzyme Q10 market from other application, by region, 2018 - 2032, (Tons) (USD Million)

Chapter 5 Global Coenzyme Q 10 Market, By Region

  • 5.1 Key regional trends
  • 5.2 North America
    • 5.2.1 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.2.2 North America coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.3.2 U.S. coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.2.4.2 Canada coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.3.2 Europe coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.3.2 Germany coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.4 UK
      • 5.3.4.1 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.4.2 UK coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.5 France
      • 5.3.5.1 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.5.2 France coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.6 Italy
      • 5.3.6.1 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.6.2 Italy coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.7 Russia
      • 5.3.7.1 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.7.2 Russia coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.3.8 Poland
      • 5.3.8.1 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.3.8.2 Poland coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.4.2 Asia Pacific coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.3.2 China coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.4 India
      • 5.4.4.1 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.4.2 India coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.4.5 Japan
      • 5.4.5.1 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.4.5.2 Japan coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.5 Latin America (LATAM)
    • 5.5.1 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.5.2 LATAM coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.3.2 Brazil coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
      • 5.5.4.2 Mexico coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)
  • 5.6 Middle East & Africa (MEA)
    • 5.6.1 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
    • 5.6.2 MEA coenzyme Q10 market, by application, 2018 - 2032, (Tons) (USD Million)

Chapter 6 Company Profiles

  • 6.1 Kaneka Corporation
    • 6.1.1 Business Overview
    • 6.1.2 Financial Data
    • 6.1.3 Product Landscape
    • 6.1.4 SWOT Analysis
  • 6.2 DSM
    • 6.2.1 Business Overview
    • 6.2.2 Financial Data
    • 6.2.3 Product Landscape
    • 6.2.4 SWOT Analysis
  • 6.3 SourceOne Global Partners, LLC
    • 6.3.1 Business Overview
    • 6.3.2 Financial Data
    • 6.3.3 Product Landscape
    • 6.3.4 SWOT Analysis
  • 6.4 Healthy Origins
    • 6.4.1 Business Overview
    • 6.4.2 Financial Data
    • 6.4.3 Product Landscape
    • 6.4.4 SWOT Analysis
  • 6.5 Vitamin Shoppe, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Data
    • 6.5.3 Product Landscape
    • 6.5.4 SWOT Analysis
  • 6.6 NBTY, Inc.
    • 6.6.1 Business Overview
    • 6.6.2 Financial Data
    • 6.6.3 Product Landscape
    • 6.6.4 SWOT Analysis
  • 6.7 Pharmavite LLC
    • 6.7.1 Business Overview
    • 6.7.2 Financial Data
    • 6.7.3 Product Landscape
    • 6.7.4 SWOT Analysis
  • 6.8 QUTEN Research Institute LLC
    • 6.8.1 Business Overview
    • 6.8.2 Financial Data
    • 6.8.3 Product Landscape
    • 6.8.4 SWOT Analysis
  • 6.9 Tishcon Corp.
    • 6.9.1 Business Overview
    • 6.9.2 Financial Data
    • 6.9.3 Product Landscape
    • 6.9.4 SWOT Analysis
  • 6.10 Country Life, LLC
    • 6.10.1 Business Overview
    • 6.10.2 Financial Data
    • 6.10.3 Product Landscape
    • 6.10.4 SWOT Analysis
  • 6.11 Natural Organics
    • 6.11.1 Business Overview
    • 6.11.2 Financial Data
    • 6.11.3 Product Landscape
    • 6.11.4 SWOT Analysis
    • 6.11.5 Strategic Outlook
  • 6.12 Jarrow Formulas
    • 6.12.1 Business Overview
    • 6.12.2 Financial Data
    • 6.12.3 Product Landscape
    • 6.12.4 SWOT Analysis
  • 6.13 NOW Foods
    • 6.13.1 Business Overview
    • 6.13.2 Financial Data
    • 6.13.3 Product Landscape
    • 6.13.4 SWOT Analysis
  • 6.14 Pharma Nord, Inc.
    • 6.14.1 Business Overview
    • 6.14.2 Financial Data
    • 6.14.3 Product Landscape
    • 6.14.4 SWOT Analysis
  • 6.15 Doctor's Best
    • 6.15.1 Business Overview
    • 6.15.2 Financial Data
    • 6.15.3 Product Landscape
    • 6.15.4 SWOT Analysis
    • 6.15.5 Strategic Outlook
  • 6.16 Xiamen Kingdomway Group
    • 6.16.1 Business Overview
    • 6.16.2 Financial Data
    • 6.16.3 Product Landscape
    • 6.16.4 SWOT Analysis
  • 6.17 GNC Holdings, Inc.
    • 6.17.1 Business Overview
    • 6.17.2 Financial Data
    • 6.17.3 Product Landscape
    • 6.17.4 SWOT Analysis
  • 6.18 Nordic Naturals, Inc.
    • 6.18.1 Business Overview
    • 6.18.2 Financial Data
    • 6.18.3 Product Landscape
    • 6.18.4 SWOT Analysis

Chapter 7 Potential Customers

  • 7.1 Merck & Co.
    • 7.1.1 Business Overview
    • 7.1.2 Financial Data
    • 7.1.3 Product Landscape
  • 7.2 Abbott Laboratories
    • 7.2.1 Business Overview
    • 7.2.2 Financial Data
    • 7.2.3 Product Landscape
  • 7.3 Sun Pharmaceutical Industries Limited
    • 7.3.1 Business Overview
    • 7.3.2 Financial Data
    • 7.3.3 Product Landscape
  • 7.4 Pfizer
    • 7.4.1 Business Overview
    • 7.4.2 Financial Data
    • 7.4.3 Product Landscape
  • 7.5 Sanofi
    • 7.5.1 Business Overview
    • 7.5.2 Financial Data
    • 7.5.3 Product Landscape
  • 7.6 Bristol Myers Squibb
    • 7.6.1 Business Overview
    • 7.6.2 Financial Data
    • 7.6.3 Product Landscape
  • 7.7 Novartis
    • 7.7.1 Business Overview
    • 7.7.2 Financial Data
    • 7.7.3 Product Landscape
  • 7.8 Johnson & Johnson
    • 7.8.1 Business Overview
    • 7.8.2 Financial Data
    • 7.8.3 Product Landscape
  • 7.9 GlaxoSmithKline
    • 7.9.1 Business Overview
    • 7.9.2 Financial Data
    • 7.9.3 Product Landscape
  • 7.10 Unilever
    • 7.10.1 Business Overview
    • 7.10.2 Financial Data
    • 7.10.3 Product Landscape
  • 7.11 Avon Products, Inc
    • 7.11.1 Business Overview
    • 7.11.2 Financial Data
    • 7.11.3 Product Landscape
  • 7.12 Beiersdorf
    • 7.12.1 Business Overview
    • 7.12.2 Financial Data
    • 7.12.3 Product Landscape
  • 7.13 Henkel AG & Co., KGaA
    • 7.13.1 Business Overview
    • 7.13.2 Financial Data
    • 7.13.3 Product Landscape
  • 7.14 Oriflame Holding AG
    • 7.14.1 Business Overview
    • 7.14.2 Financial Data
    • 7.14.3 Product Landscape
  • 7.15 The Estee Lauder Companies Inc.
    • 7.15.1 Business Overview
    • 7.15.2 Financial Data
    • 7.15.3 Product Landscape
  • 7.16 Yves Rocher
    • 7.16.1 Business Overview
    • 7.16.2 Financial Data
    • 7.16.3 Product Landscape
  • 7.17 Shiseido Company, Limited
    • 7.17.1 Business Overview
    • 7.17.2 Financial Data
    • 7.17.3 Product Landscape
  • 7.18 Bluebonnet Nutrition
    • 7.18.1 Business Overview
    • 7.18.2 Financial Data
    • 7.18.3 Product Landscape
  • 7.19 Barlean's
    • 7.19.1 Business Overview
    • 7.19.2 Financial Data
    • 7.19.3 Product Landscape
  • 7.20 Natural Factors
    • 7.20.1 Business Overview
    • 7.20.2 Financial Data
    • 7.20.3 Product Landscape
  • 7.21 LifeExtension
    • 7.21.1 Business Overview
    • 7.21.2 Financial Data
    • 7.21.3 Product Landscape

Data Tables

  • TABLE 1 Global coenzyme Q10 industry 3600 synopsis, 2023 - 2032
  • TABLE 2 Global coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 3 Global coenzyme Q10 market volume, by region, 2018 - 2032, (Tons)
  • TABLE 4 Global coenzyme Q10 market revenue, by region, 2018 - 2032, (USD Million)
  • TABLE 5 Global coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 6 Global coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 7 Vendor matrix
  • TABLE 8 CoQ10 distribution channel analysis
  • TABLE 9 Industry impact forces
  • TABLE 10 Top players overview
  • TABLE 11 Global coenzyme Q10 market from pharmaceutical application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 12 Global coenzyme Q10 market volume from pharmaceutical application, by region, 2018 - 2032, (Tons)
  • TABLE 13 Global coenzyme Q10 market revenue from pharmaceutical application, by region, 2018 - 2032, (USD Million)
  • TABLE 14 Global coenzyme Q10 market from dietary supplements application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 15 Global coenzyme Q10 market volume from dietary supplements application, by region, 2018 - 2032, (Tons)
  • TABLE 16 Global coenzyme Q10 market revenue from dietary supplements application, by region, 2018 - 2032, (USD Million)
  • TABLE 17 Global coenzyme Q10 market from cosmetics application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 18 Global coenzyme Q10 market volume from cosmetics application, by region, 2018 - 2032, (Tons)
  • TABLE 19 Global coenzyme Q10 market revenue from cosmetics application, by region, 2018 - 2032, (USD Million)
  • TABLE 20 Global coenzyme Q10 market from other application, 2018 - 2032, (Tons) (USD Million)
  • TABLE 21 Global coenzyme Q10 market volume from other application, by region, 2018 - 2032, (Tons)
  • TABLE 22 Global coenzyme Q10 market revenue from other application, by region, 2018 - 2032, (USD Million)
  • TABLE 23 North America coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 24 North America coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 25 North America coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 26 U.S. coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 27 U.S. coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 28 U.S. coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 29 Canada coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 30 Canada coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 31 Canada coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 32 Europe coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 33 Europe coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 34 Europe coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 35 Germany coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 36 Germany coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 37 Germany coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 38 UK coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 39 UK coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 40 UK coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 41 France coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 42 France coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 43 France coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 44 Italy coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 45 Italy coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 46 Italy coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 47 Russia coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 48 Russia coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 49 Russia coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 50 Poland coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 51 Poland coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 52 Poland coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 53 Asia Pacific coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 54 Asia Pacific coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 55 Asia Pacific coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 56 China coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 57 China coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 58 China coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 59 India coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 60 India coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 61 India coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 62 Japan coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 63 Japan coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 64 Japan coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 65 LATAM coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 66 LATAM coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 67 LATAM coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 68 Brazil coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 69 Brazil coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 70 Brazil coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 71 Mexico coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 72 Mexico coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 73 Mexico coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)
  • TABLE 74 MEA coenzyme Q10 market, 2018 - 2032, (Tons) (USD Million)
  • TABLE 75 MEA coenzyme Q10 market volume, by application, 2018 - 2032, (Tons)
  • TABLE 76 MEA coenzyme Q10 market revenue, by application, 2018 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 Global heart conditions & statistics, 2019, (% share)
  • FIG. 2 Global cosmetic market share by category, 2019, (% share)
  • FIG. 3 Europe cosmetic market by country, 2019, (USD billion)
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry ecosystem analysis
  • FIG. 6 Global CoQ10 market estimates and forecast, 2018 - 2032 (Tons) (USD Million)
  • FIG. 7 Coenzyme Q10 technology landscape
  • FIG. 8 Lactobacilli price trends (USD/kilo)
  • FIG. 9 North America cosmetics market, 2018, (USD Million)
  • FIG. 10 Europe diabetes data, 2019, (% share)
  • FIG. 11 Europe attributable factors risk factors for CVD, 2020, (% share)
  • FIG. 12 Asia Pacific pharmaceutical market, 2017-2031, (USD Billion)
  • FIG. 13 Growth potential analysis, 2022
  • FIG. 14 Porter's analysis
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 PESTEL analysis
  • FIG. 17 SWOT Analysis, Kaneka Corporation
  • FIG. 18 SWOT Analysis, DSM
  • FIG. 19 SWOT Analysis, SourceOne Global Partners
  • FIG. 20 SWOT Analysis, Healthy Origins
  • FIG. 21 SWOT Analysis, Vitamin Shoppe, Inc
  • FIG. 22 SWOT Analysis, Nature's Bounty Co
  • FIG. 23 SWOT Analysis, Pharmavite LLC
  • FIG. 24 SWOT Analysis, Quten Research Institute
  • FIG. 25 SWOT Analysis, Tishcon Corp
  • FIG. 26 SWOT Analysis, Country Life, LLC
  • FIG. 27 SWOT Analysis, Natural Organics
  • FIG. 28 SWOT Analysis, Jarrow Formulas
  • FIG. 29 SWOT Analysis, NOW Foods
  • FIG. 30 SWOT Analysis, Pharma Nord
  • FIG. 31 SWOT Analysis, Doctor's Best, Inc
  • FIG. 32 SWOT Analysis, Xiamen Kingdomway Group
  • FIG. 33 SWOT Analysis, GNC Holdings, Inc
  • FIG. 34 SWOT Analysis, Nordic Naturals, Inc